Shrydus Industries Ltd
Incorporation in 1983, Shrydus Industries Ltd is in the business of healthcare, pharma, real estate and green energy[1]
- Market Cap ₹ 10.8 Cr.
- Current Price ₹ 3.38
- High / Low ₹ 6.61 / 2.55
- Stock P/E
- Book Value ₹ 15.8
- Dividend Yield 0.00 %
- ROCE 24.5 %
- ROE 29.2 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.21 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- Promoter holding is low: 25.9%
- Promoter holding has decreased over last 3 years: -10.8%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2003 | Mar 2004 | Mar 2005 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|
| 0.34 | 0.53 | 0.45 | 9.45 | 39.81 | 0.20 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| 0.57 | 0.61 | 0.53 | 8.93 | 31.53 | 3.49 | |
| Financing Profit | -0.23 | -0.08 | -0.08 | 0.52 | 8.27 | -3.29 |
| Financing Margin % | -67.65% | -15.09% | -17.78% | 5.50% | 20.77% | -1,645.00% |
| 0.01 | 0.02 | 0.00 | 0.00 | 0.00 | 0.01 | |
| Depreciation | 0.04 | 0.04 | 0.04 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.26 | -0.10 | -0.12 | 0.52 | 8.27 | -3.28 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| -0.26 | -0.10 | -0.12 | 0.52 | 8.27 | -2.79 | |
| EPS in Rs | 0.16 | 2.58 | -0.87 | |||
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -100% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -127% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 16% |
| 3 Years: | -49% |
| 1 Year: | -35% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 29% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2003 | Mar 2004 | Mar 2005 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|
| Equity Capital | 6.35 | 6.35 | 6.35 | 12.01 | 32.02 | 32.02 |
| Reserves | -2.60 | -2.69 | -2.81 | -6.05 | 18.56 | 18.47 |
| Borrowing | 3.42 | 3.42 | 3.42 | 10.91 | 0.02 | 0.02 |
| 0.23 | 0.25 | 0.27 | 0.02 | 0.02 | 0.02 | |
| Total Liabilities | 7.40 | 7.33 | 7.23 | 16.89 | 50.62 | 50.53 |
| 0.52 | 0.49 | 0.45 | 0.00 | 0.01 | 0.01 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 2.91 | 2.27 | 2.27 | 0.00 | 0.00 | 0.00 |
| 3.97 | 4.57 | 4.51 | 16.89 | 50.61 | 50.52 | |
| Total Assets | 7.40 | 7.33 | 7.23 | 16.89 | 50.62 | 50.53 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2003 | Mar 2004 | Mar 2005 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| -13.46 | -25.48 | ||||
| 0.00 | -0.01 | ||||
| 12.58 | 25.46 | ||||
| Net Cash Flow | -0.88 | -0.03 | |||
| Free Cash Flow | -13.46 | -25.49 | |||
| CFO/OP | -2,588% | -308% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2003 | Mar 2004 | Mar 2005 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| ROE % | -6.93% | -2.70% | -3.33% | 8.72% | 29.25% |
Insights
In beta| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Number of Permanent Employees Number ・Standalone data |
|
||||||||
| Current Ratio Ratio ・Standalone data |
|||||||||
| Debt-Equity Ratio Ratio ・Standalone data |
|||||||||
| Trade Receivables Turnover Ratio Ratio ・Standalone data |
|||||||||
Extracted by Screener AI
Documents
Announcements
-
Board Meeting Intimation for Consider And Approve The Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Year Ended On March 31, 2026;
1d - Board meeting on 22 May 2026 to approve audited standalone and consolidated FY2026 results.
-
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
6 May - Company confirms it is not a Large Corporate and has no debt securities.
-
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
6 May - Shrydus confirms it is not a Large Corporate and has no debt securities.
-
Announcement under Regulation 30 (LODR)-Change in Management
29 Apr - Mr. Nag Bhushan Rao resigned as Independent Director effective 29 April 2026.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 7 Apr
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
SIL (formerly VCK Capital Market Services Ltd) is an integrated and diversified corporate group which has ventured into multiple businesses. It was into Agricultural Commodities and Healthcare products business and is now diversifying in Pharmaceutical Formulation Plant, Astra Lifecare Pvt. Ltd., and Green Energy sector